日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade

利用新型溶瘤病毒Jurona和免疫检查点阻断增强肝细胞癌的免疫反应和存活率

Mulu Z Tesfay ,Yuguo Zhang ,Khandoker U Ferdous ,Mika A Taylor ,Aleksandra Cios ,Randal S Shelton ,Camila C Simoes ,Chelsae R Watters ,Oumar Barro ,Natalie M Elliott ,Bahaa Mustafa ,Jean Christopher Chamcheu ,Alicia L Graham ,Charity L Washam ,Duah Alkam ,Allen Gies ,Stephanie D Byrum ,Emmanouil Giorgakis ,Steven R Post ,Thomas Kelly ,Jun Ying ,Omeed Moaven ,Chiswili Y Chabu ,Martin E Fernandez-Zapico ,Dan G Duda ,Lewis R Roberts ,Rang Govindarajan ,Mitesh J Borad ,Martin J Cannon ,Alexei G Basnakian ,Bolni M Nagalo

Discovery of Anti-CD47 Peptides as Innate Immune Checkpoint Inhibitors

发现抗 CD47 肽作为先天免疫检查点抑制剂

Bahaa Mustafa, John Fetse, Sashi Kandel, Chien-Yu Lin, Pratik Adhikary, Umar-Farouk Mamani, Yanli Liu, Mohammed Nurudeen Ibrahim, Mohammed Alahmari, Kun Cheng

Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy

发现针对 PD-L1 的环肽抑制剂用于癌症免疫治疗

John Fetse, Zhen Zhao, Hao Liu, Umar-Farouk Mamani, Bahaa Mustafa, Pratik Adhikary, Mohammed Ibrahim, Yanli Liu, Pratikkumar Patel, Maryam Nakhjiri, Mohammed Alahmari, Guangfu Li, Kun Cheng

Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy

发现用于癌症免疫治疗的抗 PD-L1 人域抗体

Hao Liu, Yanli Liu, Zhen Zhao, Yuanke Li, Bahaa Mustafa, Zhijin Chen, Ashutosh Barve, Akshay Jain, Xiaolan Yao, Guangfu Li, Kun Cheng

Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity

发现小分子抗 ACE2 肽可抑制 SARS-CoV-2 传染性

Pratik Adhikary, Sashi Kandel, Umar-Farouk Mamani, Bahaa Mustafa, Siyuan Hao, Jianming Qiu, John Fetse, Yanli Liu, Nurudeen Mohammed Ibrahim, Yongren Li, Chien-Yu Lin, Evanthia Omoscharka, Kun Cheng